New Releases from NCBI BookshelfTafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma.Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma.
Post Content
Uncategorized
New Releases from NCBI BookshelfTrastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal).Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal).
Post Content
Uncategorized
New Releases from NCBI BookshelfThe Availability, Quality, and Use of Administrative Data to Identify and Reduce Health and Human Services-Related Disparities: A Survey of HHS-Funded Programs and Interventions [Internet].The Availability, Quality, and Use of Administrative Data to Identify and Reduce Health and Human Services-Related Disparities: A Survey of HHS-Funded Programs and Interventions [Internet].
Executive Orders No. 13985 (2021) and 14091 (2023) require federal agencies to ensure that their policies and services, including data
Uncategorized
New Releases from NCBI BookshelfAbemaciclib (Verzenio): Therapeutic area: Adjuvant treatment of hormone receptor–positive, HER2-negative early breast cancer: Reimbursement Review [Internet].Abemaciclib (Verzenio): Therapeutic area: Adjuvant treatment of hormone receptor–positive, HER2-negative early breast cancer: Reimbursement Review [Internet].
Post Content
Uncategorized
New Releases from NCBI BookshelfClindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo): Therapeutic area: Acne vulgaris: Reimbursement Review [Internet].Clindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo): Therapeutic area: Acne vulgaris: Reimbursement Review [Internet].
Post Content
